Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Journal of Cardiology|October 12, 2020
Patient perspectives on left main stem revascularization strategies, the OPINION-2 studyRutger-Jan Nuis, Adeel Jadoon, Bas M van Dalen, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2019
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB TrialChun Chin Chang, Yoshinobu Onuma, Stephan Achenbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
The American Journal of Cardiology|March 5, 2004
Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)Pedro A Lemos, Chourmouzios A Arampatzis, Francesco Saia, et al.
Journal of the American College of Cardiology|June 3, 2004
Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusionsAngela Hoye, Kengo Tanabe, Pedro A Lemos, et al.
The American Journal of Cardiology|July 31, 2003
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery diseaseChourmouzios A Arampatzis, Pedro A Lemos, Kengo Tanabe, et al.
Journal of the American College of Cardiology|June 12, 2003
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Chi-hang Lee, Muzaffer Degertekin, et al.
JACC. Cardiovascular Imaging|April 25, 2022
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical TrialTijn P J Jansen, Regina E Konst, Annemiek de Vos, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Journal of Cardiology|October 12, 2020
Patient perspectives on left main stem revascularization strategies, the OPINION-2 studyRutger-Jan Nuis, Adeel Jadoon, Bas M van Dalen, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2019
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB TrialChun Chin Chang, Yoshinobu Onuma, Stephan Achenbach, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 14, 2022
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trialRobbert J de Winter, Azfar Zaman, Hironori Hara, et al.
The American Journal of Cardiology|March 5, 2004
Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry)Pedro A Lemos, Chourmouzios A Arampatzis, Francesco Saia, et al.
Journal of the American College of Cardiology|June 3, 2004
Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusionsAngela Hoye, Kengo Tanabe, Pedro A Lemos, et al.
The American Journal of Cardiology|July 31, 2003
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery diseaseChourmouzios A Arampatzis, Pedro A Lemos, Kengo Tanabe, et al.
Journal of the American College of Cardiology|June 12, 2003
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registryPedro A Lemos, Chi-hang Lee, Muzaffer Degertekin, et al.
JACC. Cardiovascular Imaging|April 25, 2022
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical TrialTijn P J Jansen, Regina E Konst, Annemiek de Vos, et al.
Pageof 19